4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-19-002982
Chairman & CEO acquired 8,125 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
SETH SANDESH · Chairman & CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-02-21 | Option exercise : show line 1 in the form | +8,125 | $0.60 | $4,875 | 161,458 | D |
Loading xslF345X03/ownership.xml…